Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 282

Similar articles for PubMed (Select 18413823)

1.

Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination.

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Giercksky KE, Nesland JM.

Clin Cancer Res. 2008 Apr 15;14(8):2341-50. doi: 10.1158/1078-0432.CCR-07-4214.

2.

Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.

Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM.

Histol Histopathol. 2009 Aug;24(8):1049-59.

PMID:
19554512
3.

Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.

Kumar S, Ghellal A, Li C, Byrne G, Haboubi N, Wang JM, Bundred N.

Cancer Res. 1999 Feb 15;59(4):856-61.

4.

Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.

Dales JP, Garcia S, Andrac L, Carpentier S, Ramuz O, Lavaut MN, Allasia C, Bonnier P, Charpin C.

Int J Oncol. 2004 May;24(5):1197-204.

PMID:
15067342
5.

The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients.

Hansen S, Grabau DA, Sørensen FB, Bak M, Vach W, Rose C.

Clin Cancer Res. 2000 Jan;6(1):139-46.

6.

[The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].

Charpin-Taranger C, Dales JP, Garcia S, Andrac-Meyer L, Ramuz O, Carpentier-Meunier S, Bonnier P.

Bull Acad Natl Med. 2003;187(6):1129-45; discussion 1145-6. French.

PMID:
14978873
7.

Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.

Safwat MD, Habib F, Elayat A, Oweiss N, Reffat S, Algaidi S.

Folia Morphol (Warsz). 2009 Aug;68(3):144-55.

PMID:
19722158
8.

Chalkley estimates of angiogenesis in early breast cancer--relevance to prognosis.

Offersen BV, Sørensen FB, Yilmaz M, Knoop A, Overgaard J; Danish Breast Cancer Cooperative Group Tumour Biology Committee.

Acta Oncol. 2002;41(7-8):695-703.

PMID:
14651216
9.

Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.

Bidard FC, Vincent-Salomon A, Gomme S, Nos C, de Rycke Y, Thiery JP, Sigal-Zafrani B, Mignot L, Sastre-Garau X, Pierga JY; Institut Curie Breast Cancer Study Group.

Clin Cancer Res. 2008 Jun 1;14(11):3306-11. doi: 10.1158/1078-0432.CCR-07-4749.

10.

Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression.

Dales JP, Garcia S, Carpentier S, Andrac L, Ramuz O, Lavaut MN, Allasia C, Bonnier P, Charpin C.

Hum Pathol. 2004 Feb;35(2):176-83.

PMID:
14991534
11.
12.

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.

Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, Yamada T, Hanaoka N, Inui K, Wada H.

Clin Cancer Res. 2001 Nov;7(11):3410-5.

13.

Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients.

Fox SB, Leek RD, Bliss J, Mansi JL, Gusterson B, Gatter KC, Harris AL.

J Natl Cancer Inst. 1997 Jul 16;89(14):1044-9.

14.

Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.

Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S.

Hum Pathol. 2006 Jul;37(7):861-6. Epub 2006 May 19.

PMID:
16784986
15.

Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.

Zvrko E, Mikic A, Vuckovic L, Djukic V, Knezevic M.

Otolaryngol Head Neck Surg. 2009 Oct;141(4):478-83. doi: 10.1016/j.otohns.2009.07.001.

PMID:
19786216
16.

Endothelial area as a prognostic indicator for invasive breast carcinoma.

Simpson JF, Ahn C, Battifora H, Esteban JM.

Cancer. 1996 May 15;77(10):2077-85.

PMID:
8640673
17.

Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.

Wiedswang G, Borgen E, Kåresen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, Naume B.

J Clin Oncol. 2003 Sep 15;21(18):3469-78.

PMID:
12972522
18.

Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer.

Offersen BV, Riisbro R, Knoop A, Brünner N, Overgaard J; Danish Breast Cancer Cooperative Group (DBCG) Tumor Biology Committee.

Acta Oncol. 2007;46(6):782-91.

PMID:
17653901
19.

CD105 expression is an independent predictor of survival in patients with endometrial cancer.

Erdem O, Taskiran C, Onan MA, Erdem M, Guner H, Ataoglu O.

Gynecol Oncol. 2006 Dec;103(3):1007-11. Epub 2006 Jul 18.

PMID:
16854456
20.

Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.

Martone T, Rosso P, Albera R, Migliaretti G, Fraire F, Pignataro L, Pruneri G, Bellone G, Cortesina G.

Oral Oncol. 2005 Feb;41(2):147-55.

PMID:
15695116
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk